Catheter Precision (VTAK) Shares Outstanding (Weighted Average) (2017 - 2026)

Catheter Precision (VTAK) has 10 years of Shares Outstanding (Weighted Average) data on file, last reported at $2.2 million in Q1 2026.

• Quarterly Shares Outstanding (Weighted Average) rose 269.06% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 269.06% YoY) and the FY2025 annual result came in at $1.4 million, up 37.3% from the prior year.
• Shares Outstanding (Weighted Average) climbed to $2.2 million in Q1 2026 per VTAK's latest filing, from $1.4 million in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $668.5 million in Q3 2022 and bottomed at $107952.0 in Q3 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $1.1 million (2023), against an average of $102.9 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Weighted Average) soared 742771011.11%; it then slumped 99.94% in 2023.
• Tracing VTAK's Shares Outstanding (Weighted Average) over 5 years: stood at $1.0 million in 2022, then increased by 6.81% to $1.1 million in 2023, then retreated by 6.41% to $1.0 million in 2024, then soared by 37.3% to $1.4 million in 2025, then surged by 54.47% to $2.2 million in 2026.
• Per Business Quant, the three latest VTAK Shares Outstanding (Weighted Average) figures stand at $2.2 million (Q1 2026), $1.4 million (Q4 2025), and $1.3 million (Q3 2025).

Peer Comparison